Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial
ANNÉE
2013
AUTEURS
Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Boige V, Bérille J, Conroy T
CONGRÈS/REVUE
J Clin Oncol
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES